148 related articles for article (PubMed ID: 8762873)
21. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
22. Salivary gland type nasopharyngeal carcinoma: a histologic, immunohistochemical, and Epstein-Barr virus study of 15 cases including a psammomatous mucoepidermoid carcinoma.
Kuo T; Tsang NM
Am J Surg Pathol; 2001 Jan; 25(1):80-6. PubMed ID: 11145255
[TBL] [Abstract][Full Text] [Related]
23. Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs.
Hao SP; Tsang NM; Chang KP
Cancer; 2003 Apr; 97(8):1909-13. PubMed ID: 12673717
[TBL] [Abstract][Full Text] [Related]
24. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells.
Chang MH; Ng CK; Lin YJ; Liang CL; Chung PJ; ChenML ; Tyan YS; Hsu CY; Shu CH; Chang YS
DNA Cell Biol; 1997 Jul; 16(7):829-37. PubMed ID: 9260926
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of Bcl-2 oncoprotein in EBV-associated nasopharyngeal carcinoma correlated to histological type and survival.
Vera-Sempere FJ; Burgos JS; Botella MS; Morera C
Histol Histopathol; 1997 Jan; 12(1):9-18. PubMed ID: 9046038
[TBL] [Abstract][Full Text] [Related]
26. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
[TBL] [Abstract][Full Text] [Related]
27. Beta 2-microglobulin and HLA-DR expression in relation to the presence of Epstein-Barr virus in nasopharyngeal carcinomas.
Kouvidou C; Rontogianni D; Tzardi M; Datseris G; Panayiotides I; Darivianaki K; Karidi E; Delides G; Kanavaros P
Pathobiology; 1995; 63(6):320-7. PubMed ID: 8738471
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus-associated nonsmall cell lung carcinoma: undifferentiated "lymphoepithelioma-like" carcinoma as a distinct entity with better prognosis.
Chen FF; Yan JJ; Lai WW; Jin YT; Su IJ
Cancer; 1998 Jun; 82(12):2334-42. PubMed ID: 9635525
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus is detected in undifferentiated nasopharyngeal carcinoma but not in lymphoepithelioma-like carcinoma of the urinary bladder.
Gulley ML; Amin MB; Nicholls JM; Banks PM; Ayala AG; Srigley JR; Eagan PA; Ro JY
Hum Pathol; 1995 Nov; 26(11):1207-14. PubMed ID: 7590694
[TBL] [Abstract][Full Text] [Related]
30. [Internal deletions of the latent membrane protein oncogenes of Epstein-Barr virus in Hodgkin's disease are almost identical with those of Asiatic nasopharyngeal carcinoma].
Odermatt BF; Heitz PU; Bachmann E; Brousset P; Sandvej K; Knecht H
Verh Dtsch Ges Pathol; 1994; 78():324-8. PubMed ID: 7534006
[TBL] [Abstract][Full Text] [Related]
31. Amino acid changes in functional domains of latent membrane protein 1 of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA A2-restricted 'epitope-loss variant'.
Lin JC; Cherng JM; Lin HJ; Tsang CW; Liu YX; Lee SP
J Gen Virol; 2004 Jul; 85(Pt 7):2023-2034. PubMed ID: 15218188
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus DNA in nasopharyngeal carcinoma in Thai patients at Ramathibodi Hospital, Bangkok.
Niemhom S; Maeda S; Raksakait K; Petchclai B
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():325-8. PubMed ID: 8629135
[TBL] [Abstract][Full Text] [Related]
33. High frequency of EBV association and 30-bp deletion in the LMP-1 gene in CD56 lymphomas of the upper aerodigestive tract.
Tai YC; Kim LH; Peh SC
Pathol Int; 2004 Mar; 54(3):158-66. PubMed ID: 14989738
[TBL] [Abstract][Full Text] [Related]
34. Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma.
Heussinger N; Büttner M; Ott G; Brachtel E; Pilch BZ; Kremmer E; Niedobitek G
J Pathol; 2004 Jun; 203(2):696-9. PubMed ID: 15141385
[TBL] [Abstract][Full Text] [Related]
35. Expression of the Epstein-Barr virus latent membrane protein in nasopharyngeal carcinoma biopsy specimens.
Stewart JP; Arrand JR
Hum Pathol; 1993 Mar; 24(3):239-42. PubMed ID: 8384158
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China.
Sung NS; Edwards RH; Seillier-Moiseiwitsch F; Perkins AG; Zeng Y; Raab-Traub N
Int J Cancer; 1998 Apr; 76(2):207-15. PubMed ID: 9537582
[TBL] [Abstract][Full Text] [Related]
37. The relationship between secretory leukocyte protease inhibitor expression and Epstein-Barr virus status among patients with nasopharyngeal carcinoma.
Tse KP; Wu CS; Hsueh C; Chang KP; Hao SP; Chang YS; Tsang NM
Anticancer Res; 2012 Apr; 32(4):1299-307. PubMed ID: 22493362
[TBL] [Abstract][Full Text] [Related]
38. Detection of LMP-1 gene in middle ear effusion of NPC.
Hao SP; Tsang NM; Chen YL; Chang KP; Su JL
Oral Oncol; 2003 Apr; 39(3):296-300. PubMed ID: 12618203
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue.
Dirnhofer S; Angeles-Angeles A; Ortiz-Hidalgo C; Reyes E; Gredler E; Krugmann J; Fend F; Quintanilla-Martinez L
Hum Pathol; 1999 Jul; 30(7):781-7. PubMed ID: 10414496
[TBL] [Abstract][Full Text] [Related]
40. Detection of Epstein-Barr virus and human papillomavirus in nasopharyngeal carcinoma by the polymerase chain reaction technique.
Giannoudis A; Ergazaki M; Segas J; Giotakis J; Adamopoulos G; Gorgoulis V; Spandidos DA
Cancer Lett; 1995 Mar; 89(2):177-81. PubMed ID: 7889526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]